Author

Yuliia Dramaretska

Max Delbrück CenterORCID 0000-0002-9792-0465Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Gaetano GargiuloiD· 2 shared Jean‐Christophe MarineiD· 2 shared Alexander M. TsankoviD· 1 shared Ali Osman ÇetiniD· 1 shared Bruno GiottiiD· 1 shared Dan HassoniD· 1 shared Daniel Lozano‐OjalvoiD· 1 shared Denis TorreiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gaetano GargiuloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedFeb 1, 2025

A Mutation-driven oncofetal regression fuels phenotypic plasticity in colorectal cancer

Slim Mzoughi, Megan Catherine Schwarz, Xuedi Wang…·Ernesto Guccione

This study identifies an oncofetal cell state that contributes to resistance in colorectal cancer and shows that targeting both this state and LGR5+ CSCs is needed for effective treatment.

97 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 29, 2024

Transcriptional Dosage of Oncogenic KRAS Drives Lung Adenocarcinoma Cell States, Progression and Metastasis

Michela Serresi, Ali Osman Çetin, Yuliia Dramaretska…·Gaetano Gargiulo

This study shows that varying levels of oncogenic KRAS drive different cell states and metastatic progression in lung adenocarcinoma, with implications for treatment.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky